nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—breast cancer—Medroxyprogesterone Acetate—uterine cancer	0.268	1	CpDpCtD
Estradiol—ESR2—uterine cancer	0.101	0.619	CbGaD
Estradiol—Trilostane—Progesterone—uterine cancer	0.0784	0.425	CrCrCtD
Estradiol—ESR1—uterine cancer	0.0622	0.381	CbGaD
Estradiol—Drostanolone—Progesterone—uterine cancer	0.0567	0.307	CrCrCtD
Estradiol—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.027	0.109	CbGbCtD
Estradiol—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.0264	0.143	CrCrCtD
Estradiol—Testosterone—Progesterone—uterine cancer	0.023	0.125	CrCrCtD
Estradiol—AR—Medroxyprogesterone Acetate—uterine cancer	0.0226	0.0909	CbGbCtD
Estradiol—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.0195	0.0785	CbGbCtD
Estradiol—SHBG—Progesterone—uterine cancer	0.0179	0.072	CbGbCtD
Estradiol—AR—Progesterone—uterine cancer	0.015	0.0602	CbGbCtD
Estradiol—SLC22A3—Progesterone—uterine cancer	0.0141	0.0566	CbGbCtD
Estradiol—ESR1—Progesterone—uterine cancer	0.0129	0.052	CbGbCtD
Estradiol—CYP1B1—Progesterone—uterine cancer	0.0129	0.052	CbGbCtD
Estradiol—ABCC10—Etoposide—uterine cancer	0.0107	0.0428	CbGbCtD
Estradiol—SLC22A2—Progesterone—uterine cancer	0.00834	0.0335	CbGbCtD
Estradiol—ABCC10—Doxorubicin—uterine cancer	0.00727	0.0292	CbGbCtD
Estradiol—SLC22A1—Progesterone—uterine cancer	0.00724	0.0291	CbGbCtD
Estradiol—CYP1A1—Progesterone—uterine cancer	0.00568	0.0228	CbGbCtD
Estradiol—UGT1A1—Etoposide—uterine cancer	0.00501	0.0201	CbGbCtD
Estradiol—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.00495	0.0199	CbGbCtD
Estradiol—ABCG2—Dactinomycin—uterine cancer	0.00488	0.0196	CbGbCtD
Estradiol—CYP3A7—Progesterone—uterine cancer	0.00454	0.0183	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.00454	0.0183	CbGbCtD
Estradiol—CYP1B1—Doxorubicin—uterine cancer	0.00395	0.0159	CbGbCtD
Estradiol—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.00345	0.0139	CbGbCtD
Estradiol—CYP3A5—Progesterone—uterine cancer	0.00341	0.0137	CbGbCtD
Estradiol—ABCG2—Carboplatin—uterine cancer	0.00328	0.0132	CbGbCtD
Estradiol—CYP2C8—Progesterone—uterine cancer	0.00328	0.0132	CbGbCtD
Estradiol—ABCG2—Etoposide—uterine cancer	0.00275	0.0111	CbGbCtD
Estradiol—CYP2C19—Progesterone—uterine cancer	0.00275	0.0111	CbGbCtD
Estradiol—CYP1A2—Progesterone—uterine cancer	0.00254	0.0102	CbGbCtD
Estradiol—CYP2C9—Progesterone—uterine cancer	0.00229	0.00919	CbGbCtD
Estradiol—ABCB1—Progesterone—uterine cancer	0.00222	0.00892	CbGbCtD
Estradiol—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00201	0.00807	CbGbCtD
Estradiol—ABCG2—Doxorubicin—uterine cancer	0.00188	0.00755	CbGbCtD
Estradiol—ABCB1—Dactinomycin—uterine cancer	0.00176	0.00707	CbGbCtD
Estradiol—CYP3A5—Etoposide—uterine cancer	0.00153	0.00613	CbGbCtD
Estradiol—CYP2C8—Etoposide—uterine cancer	0.00147	0.0059	CbGbCtD
Estradiol—CYP3A4—Progesterone—uterine cancer	0.00133	0.00534	CbGbCtD
Estradiol—CYP1A2—Etoposide—uterine cancer	0.00114	0.00456	CbGbCtD
Estradiol—ABCB1—Etoposide—uterine cancer	0.000993	0.00399	CbGbCtD
Estradiol—SHBG—semen—uterine cancer	0.000949	0.0332	CbGeAlD
Estradiol—ESR2—oviduct—uterine cancer	0.000716	0.0251	CbGeAlD
Estradiol—FABP2—epithelium—uterine cancer	0.000711	0.0249	CbGeAlD
Estradiol—FABP2—uterine cervix—uterine cancer	0.000705	0.0247	CbGeAlD
Estradiol—ESRRB—female reproductive system—uterine cancer	0.000697	0.0244	CbGeAlD
Estradiol—AR—semen—uterine cancer	0.000681	0.0238	CbGeAlD
Estradiol—ABCB1—Doxorubicin—uterine cancer	0.000677	0.00272	CbGbCtD
Estradiol—GPER1—smooth muscle tissue—uterine cancer	0.000621	0.0217	CbGeAlD
Estradiol—CYP3A4—Etoposide—uterine cancer	0.000595	0.00239	CbGbCtD
Estradiol—GPER1—endometrium—uterine cancer	0.000578	0.0202	CbGeAlD
Estradiol—GPER1—uterus—uterine cancer	0.000533	0.0186	CbGeAlD
Estradiol—AR—oviduct—uterine cancer	0.0005	0.0175	CbGeAlD
Estradiol—ESR1—oviduct—uterine cancer	0.000491	0.0172	CbGeAlD
Estradiol—GPER1—female reproductive system—uterine cancer	0.000479	0.0168	CbGeAlD
Estradiol—GPER1—vagina—uterine cancer	0.000433	0.0152	CbGeAlD
Estradiol—CYP3A4—Doxorubicin—uterine cancer	0.000406	0.00163	CbGbCtD
Estradiol—ESRRA—myometrium—uterine cancer	0.000382	0.0134	CbGeAlD
Estradiol—Fulvestrant—ESR2—uterine cancer	0.00033	0.147	CrCbGaD
Estradiol—FABP2—lymph node—uterine cancer	0.000309	0.0108	CbGeAlD
Estradiol—ESRRA—uterine cervix—uterine cancer	0.000297	0.0104	CbGeAlD
Estradiol—ESRRA—decidua—uterine cancer	0.000283	0.00991	CbGeAlD
Estradiol—GPER1—lymph node—uterine cancer	0.00028	0.0098	CbGeAlD
Estradiol—ESRRA—renal system—uterine cancer	0.000278	0.00973	CbGeAlD
Estradiol—ESRRA—endometrium—uterine cancer	0.000269	0.0094	CbGeAlD
Estradiol—ESRRA—mammalian vulva—uterine cancer	0.00026	0.0091	CbGeAlD
Estradiol—SLCO4A1—myometrium—uterine cancer	0.000258	0.00904	CbGeAlD
Estradiol—ESRRA—uterus—uterine cancer	0.000248	0.00867	CbGeAlD
Estradiol—SLCO1C1—renal system—uterine cancer	0.000235	0.00821	CbGeAlD
Estradiol—SLC22A11—renal system—uterine cancer	0.000228	0.00798	CbGeAlD
Estradiol—ESRRA—female reproductive system—uterine cancer	0.000223	0.00779	CbGeAlD
Estradiol—AOX1—myometrium—uterine cancer	0.000221	0.00772	CbGeAlD
Estradiol—ABCC10—myometrium—uterine cancer	0.000215	0.00751	CbGeAlD
Estradiol—SLCO1B3—vagina—uterine cancer	0.000207	0.00725	CbGeAlD
Estradiol—Fulvestrant—ESR1—uterine cancer	0.000203	0.0908	CrCbGaD
Estradiol—ESRRA—female gonad—uterine cancer	0.000203	0.00709	CbGeAlD
Estradiol—ESRRA—vagina—uterine cancer	0.000201	0.00705	CbGeAlD
Estradiol—UGT1A1—renal system—uterine cancer	0.000199	0.00696	CbGeAlD
Estradiol—SLC22A2—renal system—uterine cancer	0.000198	0.00693	CbGeAlD
Estradiol—SLCO4A1—decidua—uterine cancer	0.000192	0.0067	CbGeAlD
Estradiol—SLCO4A1—renal system—uterine cancer	0.000188	0.00658	CbGeAlD
Estradiol—SLC22A3—myometrium—uterine cancer	0.000184	0.00643	CbGeAlD
Estradiol—SLC22A11—female reproductive system—uterine cancer	0.000183	0.00639	CbGeAlD
Estradiol—SLCO4A1—endometrium—uterine cancer	0.000182	0.00636	CbGeAlD
Estradiol—ESR2—epithelium—uterine cancer	0.00018	0.00629	CbGeAlD
Estradiol—ESR2—uterine cervix—uterine cancer	0.000178	0.00624	CbGeAlD
Estradiol—SLCO4A1—mammalian vulva—uterine cancer	0.000176	0.00616	CbGeAlD
Estradiol—ESR2—smooth muscle tissue—uterine cancer	0.000173	0.00606	CbGeAlD
Estradiol—AOX1—uterine cervix—uterine cancer	0.000172	0.00601	CbGeAlD
Estradiol—Trilostane—ESR2—uterine cancer	0.000169	0.0755	CrCbGaD
Estradiol—ABCC10—uterine cervix—uterine cancer	0.000167	0.00585	CbGeAlD
Estradiol—ESR2—renal system—uterine cancer	0.000167	0.00584	CbGeAlD
Estradiol—SLCO1B1—renal system—uterine cancer	0.000166	0.00579	CbGeAlD
Estradiol—AOX1—decidua—uterine cancer	0.000164	0.00572	CbGeAlD
Estradiol—ESR2—endometrium—uterine cancer	0.000161	0.00564	CbGeAlD
Estradiol—AOX1—renal system—uterine cancer	0.000161	0.00562	CbGeAlD
Estradiol—AR—myometrium—uterine cancer	0.00016	0.00559	CbGeAlD
Estradiol—ABCC10—decidua—uterine cancer	0.000159	0.00557	CbGeAlD
Estradiol—ESR1—myometrium—uterine cancer	0.000157	0.00549	CbGeAlD
Estradiol—SHBG—endometrium—uterine cancer	0.000157	0.00549	CbGeAlD
Estradiol—ABCC10—renal system—uterine cancer	0.000156	0.00547	CbGeAlD
Estradiol—AOX1—endometrium—uterine cancer	0.000155	0.00543	CbGeAlD
Estradiol—ABCC10—endometrium—uterine cancer	0.000151	0.00529	CbGeAlD
Estradiol—SLCO4A1—female reproductive system—uterine cancer	0.000151	0.00527	CbGeAlD
Estradiol—AOX1—mammalian vulva—uterine cancer	0.00015	0.00525	CbGeAlD
Estradiol—SLCO2B1—decidua—uterine cancer	0.000149	0.00522	CbGeAlD
Estradiol—ESR2—uterus—uterine cancer	0.000149	0.0052	CbGeAlD
Estradiol—Estriol—ESR2—uterine cancer	0.000147	0.0659	CrCbGaD
Estradiol—SLCO2B1—renal system—uterine cancer	0.000146	0.00512	CbGeAlD
Estradiol—ABCC10—mammalian vulva—uterine cancer	0.000146	0.00511	CbGeAlD
Estradiol—SHBG—uterus—uterine cancer	0.000144	0.00506	CbGeAlD
Estradiol—AOX1—uterus—uterine cancer	0.000143	0.00501	CbGeAlD
Estradiol—SLC22A3—uterine cervix—uterine cancer	0.000143	0.005	CbGeAlD
Estradiol—SLC22A1—renal system—uterine cancer	0.00014	0.0049	CbGeAlD
Estradiol—ABCC10—uterus—uterine cancer	0.000139	0.00487	CbGeAlD
Estradiol—SLC22A3—smooth muscle tissue—uterine cancer	0.000139	0.00486	CbGeAlD
Estradiol—Quinestrol—ESR1—uterine cancer	0.000137	0.0614	CrCbGaD
Estradiol—Estramustine—ESR2—uterine cancer	0.000137	0.0612	CrCbGaD
Estradiol—SLCO4A1—vagina—uterine cancer	0.000136	0.00477	CbGeAlD
Estradiol—SLCO1A2—renal system—uterine cancer	0.000135	0.00471	CbGeAlD
Estradiol—SLC22A3—renal system—uterine cancer	0.000134	0.00468	CbGeAlD
Estradiol—ESR2—female reproductive system—uterine cancer	0.000134	0.00468	CbGeAlD
Estradiol—SLCO1B1—female reproductive system—uterine cancer	0.000133	0.00464	CbGeAlD
Estradiol—SLCO2B1—uterus—uterine cancer	0.00013	0.00456	CbGeAlD
Estradiol—ESRRA—lymph node—uterine cancer	0.00013	0.00456	CbGeAlD
Estradiol—SHBG—female reproductive system—uterine cancer	0.00013	0.00454	CbGeAlD
Estradiol—SLC22A3—endometrium—uterine cancer	0.000129	0.00452	CbGeAlD
Estradiol—SLC22A8—renal system—uterine cancer	0.000129	0.0045	CbGeAlD
Estradiol—AOX1—female reproductive system—uterine cancer	0.000129	0.0045	CbGeAlD
Estradiol—CYP1B1—smooth muscle tissue—uterine cancer	0.000128	0.00447	CbGeAlD
Estradiol—ABCG2—myometrium—uterine cancer	0.000126	0.0044	CbGeAlD
Estradiol—AR—epithelium—uterine cancer	0.000125	0.00439	CbGeAlD
Estradiol—ABCC10—female reproductive system—uterine cancer	0.000125	0.00438	CbGeAlD
Estradiol—CYP1B1—decidua—uterine cancer	0.000125	0.00438	CbGeAlD
Estradiol—SLC22A3—mammalian vulva—uterine cancer	0.000125	0.00438	CbGeAlD
Estradiol—AR—uterine cervix—uterine cancer	0.000124	0.00435	CbGeAlD
Estradiol—ESR1—epithelium—uterine cancer	0.000123	0.00431	CbGeAlD
Estradiol—CYP1B1—renal system—uterine cancer	0.000123	0.0043	CbGeAlD
Estradiol—ESR1—uterine cervix—uterine cancer	0.000122	0.00427	CbGeAlD
Estradiol—ESR2—female gonad—uterine cancer	0.000122	0.00425	CbGeAlD
Estradiol—AR—smooth muscle tissue—uterine cancer	0.000121	0.00423	CbGeAlD
Estradiol—ESR2—vagina—uterine cancer	0.000121	0.00423	CbGeAlD
Estradiol—ESR1—smooth muscle tissue—uterine cancer	0.000119	0.00415	CbGeAlD
Estradiol—AR—decidua—uterine cancer	0.000119	0.00415	CbGeAlD
Estradiol—SHBG—female gonad—uterine cancer	0.000118	0.00414	CbGeAlD
Estradiol—SHBG—vagina—uterine cancer	0.000117	0.00411	CbGeAlD
Estradiol—SLCO2B1—female reproductive system—uterine cancer	0.000117	0.0041	CbGeAlD
Estradiol—AOX1—female gonad—uterine cancer	0.000117	0.00409	CbGeAlD
Estradiol—AR—renal system—uterine cancer	0.000116	0.00407	CbGeAlD
Estradiol—ESR1—decidua—uterine cancer	0.000116	0.00407	CbGeAlD
Estradiol—AOX1—vagina—uterine cancer	0.000116	0.00407	CbGeAlD
Estradiol—ESR1—renal system—uterine cancer	0.000114	0.004	CbGeAlD
Estradiol—ABCC10—female gonad—uterine cancer	0.000114	0.00399	CbGeAlD
Estradiol—ABCC10—vagina—uterine cancer	0.000113	0.00396	CbGeAlD
Estradiol—Estropipate—ESR2—uterine cancer	0.000113	0.0504	CrCbGaD
Estradiol—AR—endometrium—uterine cancer	0.000113	0.00394	CbGeAlD
Estradiol—ESR1—endometrium—uterine cancer	0.00011	0.00387	CbGeAlD
Estradiol—SLCO1C1—lymph node—uterine cancer	0.00011	0.00385	CbGeAlD
Estradiol—CYP1B1—uterus—uterine cancer	0.000109	0.00383	CbGeAlD
Estradiol—AR—mammalian vulva—uterine cancer	0.000109	0.00381	CbGeAlD
Estradiol—Drostanolone—CYP19A1—uterine cancer	0.000108	0.0482	CrCbGaD
Estradiol—SLC22A3—female reproductive system—uterine cancer	0.000107	0.00375	CbGeAlD
Estradiol—SLCO2B1—female gonad—uterine cancer	0.000107	0.00373	CbGeAlD
Estradiol—Mestranol—ESR1—uterine cancer	0.000104	0.0465	CrCbGaD
Estradiol—Trilostane—ESR1—uterine cancer	0.000104	0.0465	CrCbGaD
Estradiol—AR—uterus—uterine cancer	0.000104	0.00363	CbGeAlD
Estradiol—ESR1—uterus—uterine cancer	0.000102	0.00356	CbGeAlD
Estradiol—SLC22A1—vagina—uterine cancer	0.000101	0.00355	CbGeAlD
Estradiol—CYP1B1—female reproductive system—uterine cancer	9.84e-05	0.00344	CbGeAlD
Estradiol—ABCG2—uterine cervix—uterine cancer	9.78e-05	0.00342	CbGeAlD
Estradiol—SLC22A3—female gonad—uterine cancer	9.74e-05	0.00341	CbGeAlD
Estradiol—SLC22A3—vagina—uterine cancer	9.68e-05	0.00339	CbGeAlD
Estradiol—CYP2C8—renal system—uterine cancer	9.41e-05	0.00329	CbGeAlD
Estradiol—CYP1A1—epithelium—uterine cancer	9.37e-05	0.00328	CbGeAlD
Estradiol—AR—female reproductive system—uterine cancer	9.32e-05	0.00326	CbGeAlD
Estradiol—ABCG2—decidua—uterine cancer	9.32e-05	0.00326	CbGeAlD
Estradiol—CYP1A1—uterine cervix—uterine cancer	9.29e-05	0.00325	CbGeAlD
Estradiol—ESR1—female reproductive system—uterine cancer	9.15e-05	0.0032	CbGeAlD
Estradiol—CYP2C8—endometrium—uterine cancer	9.1e-05	0.00318	CbGeAlD
Estradiol—Estriol—ESR1—uterine cancer	9.08e-05	0.0406	CrCbGaD
Estradiol—CYP3A5—uterine cervix—uterine cancer	9.08e-05	0.00318	CbGeAlD
Estradiol—CYP1B1—female gonad—uterine cancer	8.96e-05	0.00313	CbGeAlD
Estradiol—ABCG2—endometrium—uterine cancer	8.85e-05	0.0031	CbGeAlD
Estradiol—SLCO4A1—lymph node—uterine cancer	8.81e-05	0.00308	CbGeAlD
Estradiol—CYP1A2—renal system—uterine cancer	8.81e-05	0.00308	CbGeAlD
Estradiol—CYP1A1—renal system—uterine cancer	8.69e-05	0.00304	CbGeAlD
Estradiol—ABCG2—mammalian vulva—uterine cancer	8.56e-05	0.00299	CbGeAlD
Estradiol—CYP3A5—renal system—uterine cancer	8.5e-05	0.00297	CbGeAlD
Estradiol—AR—female gonad—uterine cancer	8.48e-05	0.00297	CbGeAlD
Estradiol—Estramustine—ESR1—uterine cancer	8.45e-05	0.0377	CrCbGaD
Estradiol—AR—vagina—uterine cancer	8.43e-05	0.00295	CbGeAlD
Estradiol—ESR1—female gonad—uterine cancer	8.33e-05	0.00291	CbGeAlD
Estradiol—ESR1—vagina—uterine cancer	8.28e-05	0.0029	CbGeAlD
Estradiol—ABCG2—uterus—uterine cancer	8.15e-05	0.00285	CbGeAlD
Estradiol—CYP1A1—mammalian vulva—uterine cancer	8.12e-05	0.00284	CbGeAlD
Estradiol—Ethinyl Estradiol—ESR2—uterine cancer	8.06e-05	0.036	CrCbGaD
Estradiol—ESR2—lymph node—uterine cancer	7.82e-05	0.00273	CbGeAlD
Estradiol—CYP2C19—vagina—uterine cancer	7.81e-05	0.00273	CbGeAlD
Estradiol—CYP1A1—uterus—uterine cancer	7.74e-05	0.00271	CbGeAlD
Estradiol—CYP2C8—female reproductive system—uterine cancer	7.54e-05	0.00264	CbGeAlD
Estradiol—AOX1—lymph node—uterine cancer	7.52e-05	0.00263	CbGeAlD
Estradiol—ABCC10—lymph node—uterine cancer	7.32e-05	0.00256	CbGeAlD
Estradiol—Conjugated Estrogens—ESR2—uterine cancer	7.04e-05	0.0314	CrCbGaD
Estradiol—Estrone—ESR2—uterine cancer	7.02e-05	0.0313	CrCbGaD
Estradiol—CYP1A1—female reproductive system—uterine cancer	6.96e-05	0.00243	CbGeAlD
Estradiol—Estropipate—ESR1—uterine cancer	6.95e-05	0.031	CrCbGaD
Estradiol—SLCO2B1—lymph node—uterine cancer	6.86e-05	0.0024	CbGeAlD
Estradiol—CYP2C8—vagina—uterine cancer	6.82e-05	0.00239	CbGeAlD
Estradiol—CYP2C9—female reproductive system—uterine cancer	6.7e-05	0.00234	CbGeAlD
Estradiol—ABCG2—female gonad—uterine cancer	6.67e-05	0.00233	CbGeAlD
Estradiol—ABCG2—vagina—uterine cancer	6.63e-05	0.00232	CbGeAlD
Estradiol—CYP3A4—renal system—uterine cancer	6.38e-05	0.00223	CbGeAlD
Estradiol—CYP1A1—female gonad—uterine cancer	6.33e-05	0.00222	CbGeAlD
Estradiol—CYP1A1—vagina—uterine cancer	6.29e-05	0.0022	CbGeAlD
Estradiol—ALB—lymph node—uterine cancer	6.27e-05	0.0022	CbGeAlD
Estradiol—SLC22A3—lymph node—uterine cancer	6.26e-05	0.00219	CbGeAlD
Estradiol—ABCB1—myometrium—uterine cancer	6.2e-05	0.00217	CbGeAlD
Estradiol—CYP3A5—female gonad—uterine cancer	6.19e-05	0.00217	CbGeAlD
Estradiol—CYP3A5—vagina—uterine cancer	6.15e-05	0.00215	CbGeAlD
Estradiol—CYP1B1—lymph node—uterine cancer	5.76e-05	0.00201	CbGeAlD
Estradiol—Testosterone—CYP11A1—uterine cancer	5.52e-05	0.0247	CrCbGaD
Estradiol—AR—lymph node—uterine cancer	5.45e-05	0.00191	CbGeAlD
Estradiol—ESR1—lymph node—uterine cancer	5.35e-05	0.00187	CbGeAlD
Estradiol—CYP3A4—female reproductive system—uterine cancer	5.11e-05	0.00179	CbGeAlD
Estradiol—Ethinyl Estradiol—ESR1—uterine cancer	4.96e-05	0.0222	CrCbGaD
Estradiol—ABCB1—epithelium—uterine cancer	4.87e-05	0.0017	CbGeAlD
Estradiol—ABCB1—uterine cervix—uterine cancer	4.82e-05	0.00169	CbGeAlD
Estradiol—ABCB1—decidua—uterine cancer	4.6e-05	0.00161	CbGeAlD
Estradiol—ABCB1—renal system—uterine cancer	4.51e-05	0.00158	CbGeAlD
Estradiol—ABCB1—endometrium—uterine cancer	4.36e-05	0.00153	CbGeAlD
Estradiol—Conjugated Estrogens—ESR1—uterine cancer	4.34e-05	0.0194	CrCbGaD
Estradiol—Estrone—ESR1—uterine cancer	4.32e-05	0.0193	CrCbGaD
Estradiol—ABCG2—lymph node—uterine cancer	4.29e-05	0.0015	CbGeAlD
Estradiol—ABCB1—mammalian vulva—uterine cancer	4.22e-05	0.00148	CbGeAlD
Estradiol—CYP1A1—lymph node—uterine cancer	4.07e-05	0.00142	CbGeAlD
Estradiol—ABCB1—uterus—uterine cancer	4.02e-05	0.00141	CbGeAlD
Estradiol—ABCB1—female reproductive system—uterine cancer	3.61e-05	0.00126	CbGeAlD
Estradiol—ABCB1—female gonad—uterine cancer	3.29e-05	0.00115	CbGeAlD
Estradiol—ABCB1—vagina—uterine cancer	3.27e-05	0.00114	CbGeAlD
Estradiol—Testosterone—CYP19A1—uterine cancer	2.86e-05	0.0128	CrCbGaD
Estradiol—ABCB1—lymph node—uterine cancer	2.11e-05	0.00074	CbGeAlD
Estradiol—Alanine aminotransferase increased—Epirubicin—uterine cancer	1.79e-05	0.000228	CcSEcCtD
Estradiol—Anaphylactic shock—Etoposide—uterine cancer	1.78e-05	0.000227	CcSEcCtD
Estradiol—Mood swings—Doxorubicin—uterine cancer	1.78e-05	0.000227	CcSEcCtD
Estradiol—Infection—Etoposide—uterine cancer	1.77e-05	0.000225	CcSEcCtD
Estradiol—Abdominal distension—Epirubicin—uterine cancer	1.77e-05	0.000225	CcSEcCtD
Estradiol—Asthenia—Dactinomycin—uterine cancer	1.77e-05	0.000225	CcSEcCtD
Estradiol—Dysphagia—Epirubicin—uterine cancer	1.76e-05	0.000224	CcSEcCtD
Estradiol—Influenza—Epirubicin—uterine cancer	1.76e-05	0.000224	CcSEcCtD
Estradiol—Asthma—Epirubicin—uterine cancer	1.76e-05	0.000224	CcSEcCtD
Estradiol—Tachycardia—Etoposide—uterine cancer	1.74e-05	0.000221	CcSEcCtD
Estradiol—Liver function test abnormal—Doxorubicin—uterine cancer	1.74e-05	0.000221	CcSEcCtD
Estradiol—Skin disorder—Etoposide—uterine cancer	1.73e-05	0.00022	CcSEcCtD
Estradiol—Dry skin—Doxorubicin—uterine cancer	1.72e-05	0.000219	CcSEcCtD
Estradiol—Hyperhidrosis—Etoposide—uterine cancer	1.72e-05	0.000219	CcSEcCtD
Estradiol—Pancreatitis—Epirubicin—uterine cancer	1.72e-05	0.000219	CcSEcCtD
Estradiol—Abdominal pain upper—Doxorubicin—uterine cancer	1.72e-05	0.000219	CcSEcCtD
Estradiol—Breast disorder—Doxorubicin—uterine cancer	1.7e-05	0.000216	CcSEcCtD
Estradiol—Bronchitis—Epirubicin—uterine cancer	1.69e-05	0.000215	CcSEcCtD
Estradiol—Diarrhoea—Dactinomycin—uterine cancer	1.69e-05	0.000214	CcSEcCtD
Estradiol—Nasopharyngitis—Doxorubicin—uterine cancer	1.68e-05	0.000214	CcSEcCtD
Estradiol—Gastritis—Doxorubicin—uterine cancer	1.67e-05	0.000212	CcSEcCtD
Estradiol—Alanine aminotransferase increased—Doxorubicin—uterine cancer	1.66e-05	0.000211	CcSEcCtD
Estradiol—Abdominal distension—Doxorubicin—uterine cancer	1.64e-05	0.000208	CcSEcCtD
Estradiol—Upper respiratory tract infection—Epirubicin—uterine cancer	1.63e-05	0.000208	CcSEcCtD
Estradiol—Asthma—Doxorubicin—uterine cancer	1.63e-05	0.000207	CcSEcCtD
Estradiol—Influenza—Doxorubicin—uterine cancer	1.63e-05	0.000207	CcSEcCtD
Estradiol—Dysphagia—Doxorubicin—uterine cancer	1.63e-05	0.000207	CcSEcCtD
Estradiol—Pollakiuria—Epirubicin—uterine cancer	1.62e-05	0.000207	CcSEcCtD
Estradiol—Photosensitivity reaction—Epirubicin—uterine cancer	1.6e-05	0.000204	CcSEcCtD
Estradiol—Paraesthesia—Etoposide—uterine cancer	1.6e-05	0.000204	CcSEcCtD
Estradiol—Weight increased—Epirubicin—uterine cancer	1.6e-05	0.000203	CcSEcCtD
Estradiol—Pancreatitis—Doxorubicin—uterine cancer	1.59e-05	0.000203	CcSEcCtD
Estradiol—Weight decreased—Epirubicin—uterine cancer	1.59e-05	0.000202	CcSEcCtD
Estradiol—Dyspnoea—Etoposide—uterine cancer	1.59e-05	0.000202	CcSEcCtD
Estradiol—Hyperglycaemia—Epirubicin—uterine cancer	1.59e-05	0.000202	CcSEcCtD
Estradiol—Somnolence—Etoposide—uterine cancer	1.59e-05	0.000202	CcSEcCtD
Estradiol—Pneumonia—Epirubicin—uterine cancer	1.58e-05	0.000201	CcSEcCtD
Estradiol—Infestation NOS—Epirubicin—uterine cancer	1.57e-05	0.000199	CcSEcCtD
Estradiol—Infestation—Epirubicin—uterine cancer	1.57e-05	0.000199	CcSEcCtD
Estradiol—Vomiting—Dactinomycin—uterine cancer	1.57e-05	0.000199	CcSEcCtD
Estradiol—Bronchitis—Doxorubicin—uterine cancer	1.56e-05	0.000199	CcSEcCtD
Estradiol—Rash—Dactinomycin—uterine cancer	1.55e-05	0.000198	CcSEcCtD
Estradiol—Decreased appetite—Etoposide—uterine cancer	1.55e-05	0.000197	CcSEcCtD
Estradiol—Gastrointestinal disorder—Etoposide—uterine cancer	1.54e-05	0.000196	CcSEcCtD
Estradiol—Fatigue—Etoposide—uterine cancer	1.54e-05	0.000196	CcSEcCtD
Estradiol—Neuropathy peripheral—Epirubicin—uterine cancer	1.54e-05	0.000195	CcSEcCtD
Estradiol—Jaundice—Epirubicin—uterine cancer	1.53e-05	0.000194	CcSEcCtD
Estradiol—Constipation—Etoposide—uterine cancer	1.52e-05	0.000194	CcSEcCtD
Estradiol—Pain—Etoposide—uterine cancer	1.52e-05	0.000194	CcSEcCtD
Estradiol—Conjunctivitis—Epirubicin—uterine cancer	1.52e-05	0.000194	CcSEcCtD
Estradiol—Urinary tract infection—Epirubicin—uterine cancer	1.52e-05	0.000194	CcSEcCtD
Estradiol—Upper respiratory tract infection—Doxorubicin—uterine cancer	1.51e-05	0.000192	CcSEcCtD
Estradiol—Pollakiuria—Doxorubicin—uterine cancer	1.5e-05	0.000191	CcSEcCtD
Estradiol—Haematuria—Epirubicin—uterine cancer	1.49e-05	0.00019	CcSEcCtD
Estradiol—Photosensitivity reaction—Doxorubicin—uterine cancer	1.48e-05	0.000189	CcSEcCtD
Estradiol—Hepatobiliary disease—Epirubicin—uterine cancer	1.48e-05	0.000189	CcSEcCtD
Estradiol—Weight increased—Doxorubicin—uterine cancer	1.48e-05	0.000188	CcSEcCtD
Estradiol—Epistaxis—Epirubicin—uterine cancer	1.48e-05	0.000188	CcSEcCtD
Estradiol—Weight decreased—Doxorubicin—uterine cancer	1.47e-05	0.000187	CcSEcCtD
Estradiol—Sinusitis—Epirubicin—uterine cancer	1.47e-05	0.000187	CcSEcCtD
Estradiol—Feeling abnormal—Etoposide—uterine cancer	1.47e-05	0.000187	CcSEcCtD
Estradiol—Hyperglycaemia—Doxorubicin—uterine cancer	1.47e-05	0.000187	CcSEcCtD
Estradiol—Nausea—Dactinomycin—uterine cancer	1.46e-05	0.000186	CcSEcCtD
Estradiol—Pneumonia—Doxorubicin—uterine cancer	1.46e-05	0.000186	CcSEcCtD
Estradiol—Gastrointestinal pain—Etoposide—uterine cancer	1.46e-05	0.000185	CcSEcCtD
Estradiol—Infestation NOS—Doxorubicin—uterine cancer	1.45e-05	0.000184	CcSEcCtD
Estradiol—Infestation—Doxorubicin—uterine cancer	1.45e-05	0.000184	CcSEcCtD
Estradiol—Neuropathy peripheral—Doxorubicin—uterine cancer	1.42e-05	0.000181	CcSEcCtD
Estradiol—Urticaria—Etoposide—uterine cancer	1.42e-05	0.00018	CcSEcCtD
Estradiol—Haemoglobin—Epirubicin—uterine cancer	1.41e-05	0.00018	CcSEcCtD
Estradiol—Jaundice—Doxorubicin—uterine cancer	1.41e-05	0.00018	CcSEcCtD
Estradiol—Rhinitis—Epirubicin—uterine cancer	1.41e-05	0.000179	CcSEcCtD
Estradiol—Abdominal pain—Etoposide—uterine cancer	1.41e-05	0.000179	CcSEcCtD
Estradiol—Body temperature increased—Etoposide—uterine cancer	1.41e-05	0.000179	CcSEcCtD
Estradiol—Conjunctivitis—Doxorubicin—uterine cancer	1.41e-05	0.000179	CcSEcCtD
Estradiol—Urinary tract infection—Doxorubicin—uterine cancer	1.41e-05	0.000179	CcSEcCtD
Estradiol—Hepatitis—Epirubicin—uterine cancer	1.41e-05	0.000179	CcSEcCtD
Estradiol—Haemorrhage—Epirubicin—uterine cancer	1.41e-05	0.000179	CcSEcCtD
Estradiol—Hypoaesthesia—Epirubicin—uterine cancer	1.4e-05	0.000178	CcSEcCtD
Estradiol—Pharyngitis—Epirubicin—uterine cancer	1.4e-05	0.000178	CcSEcCtD
Estradiol—Urinary tract disorder—Epirubicin—uterine cancer	1.39e-05	0.000177	CcSEcCtD
Estradiol—Oedema peripheral—Epirubicin—uterine cancer	1.39e-05	0.000176	CcSEcCtD
Estradiol—Haematuria—Doxorubicin—uterine cancer	1.38e-05	0.000176	CcSEcCtD
Estradiol—Connective tissue disorder—Epirubicin—uterine cancer	1.38e-05	0.000176	CcSEcCtD
Estradiol—Urethral disorder—Epirubicin—uterine cancer	1.38e-05	0.000175	CcSEcCtD
Estradiol—Hepatobiliary disease—Doxorubicin—uterine cancer	1.37e-05	0.000174	CcSEcCtD
Estradiol—Epistaxis—Doxorubicin—uterine cancer	1.37e-05	0.000174	CcSEcCtD
Estradiol—Sinusitis—Doxorubicin—uterine cancer	1.36e-05	0.000173	CcSEcCtD
Estradiol—Visual impairment—Epirubicin—uterine cancer	1.36e-05	0.000172	CcSEcCtD
Estradiol—Erythema multiforme—Epirubicin—uterine cancer	1.33e-05	0.000169	CcSEcCtD
Estradiol—Eye disorder—Epirubicin—uterine cancer	1.31e-05	0.000167	CcSEcCtD
Estradiol—Hypersensitivity—Etoposide—uterine cancer	1.31e-05	0.000167	CcSEcCtD
Estradiol—Tinnitus—Epirubicin—uterine cancer	1.31e-05	0.000167	CcSEcCtD
Estradiol—Haemoglobin—Doxorubicin—uterine cancer	1.31e-05	0.000166	CcSEcCtD
Estradiol—Flushing—Epirubicin—uterine cancer	1.31e-05	0.000166	CcSEcCtD
Estradiol—Cardiac disorder—Epirubicin—uterine cancer	1.31e-05	0.000166	CcSEcCtD
Estradiol—Rhinitis—Doxorubicin—uterine cancer	1.31e-05	0.000166	CcSEcCtD
Estradiol—Hepatitis—Doxorubicin—uterine cancer	1.3e-05	0.000166	CcSEcCtD
Estradiol—Haemorrhage—Doxorubicin—uterine cancer	1.3e-05	0.000166	CcSEcCtD
Estradiol—Hypoaesthesia—Doxorubicin—uterine cancer	1.3e-05	0.000165	CcSEcCtD
Estradiol—Pharyngitis—Doxorubicin—uterine cancer	1.29e-05	0.000164	CcSEcCtD
Estradiol—Urinary tract disorder—Doxorubicin—uterine cancer	1.29e-05	0.000164	CcSEcCtD
Estradiol—Oedema peripheral—Doxorubicin—uterine cancer	1.28e-05	0.000163	CcSEcCtD
Estradiol—Asthenia—Etoposide—uterine cancer	1.28e-05	0.000163	CcSEcCtD
Estradiol—Connective tissue disorder—Doxorubicin—uterine cancer	1.28e-05	0.000163	CcSEcCtD
Estradiol—Angiopathy—Epirubicin—uterine cancer	1.28e-05	0.000162	CcSEcCtD
Estradiol—Urethral disorder—Doxorubicin—uterine cancer	1.28e-05	0.000162	CcSEcCtD
Estradiol—Immune system disorder—Epirubicin—uterine cancer	1.27e-05	0.000162	CcSEcCtD
Estradiol—Mediastinal disorder—Epirubicin—uterine cancer	1.27e-05	0.000161	CcSEcCtD
Estradiol—Chills—Epirubicin—uterine cancer	1.26e-05	0.000161	CcSEcCtD
Estradiol—Pruritus—Etoposide—uterine cancer	1.26e-05	0.00016	CcSEcCtD
Estradiol—Visual impairment—Doxorubicin—uterine cancer	1.25e-05	0.00016	CcSEcCtD
Estradiol—Alopecia—Epirubicin—uterine cancer	1.24e-05	0.000158	CcSEcCtD
Estradiol—Mental disorder—Epirubicin—uterine cancer	1.23e-05	0.000157	CcSEcCtD
Estradiol—Erythema multiforme—Doxorubicin—uterine cancer	1.23e-05	0.000157	CcSEcCtD
Estradiol—Erythema—Epirubicin—uterine cancer	1.22e-05	0.000156	CcSEcCtD
Estradiol—Malnutrition—Epirubicin—uterine cancer	1.22e-05	0.000156	CcSEcCtD
Estradiol—Diarrhoea—Etoposide—uterine cancer	1.22e-05	0.000155	CcSEcCtD
Estradiol—Eye disorder—Doxorubicin—uterine cancer	1.22e-05	0.000155	CcSEcCtD
Estradiol—Tinnitus—Doxorubicin—uterine cancer	1.21e-05	0.000154	CcSEcCtD
Estradiol—Cardiac disorder—Doxorubicin—uterine cancer	1.21e-05	0.000154	CcSEcCtD
Estradiol—Flushing—Doxorubicin—uterine cancer	1.21e-05	0.000154	CcSEcCtD
Estradiol—Flatulence—Epirubicin—uterine cancer	1.21e-05	0.000154	CcSEcCtD
Estradiol—Tension—Epirubicin—uterine cancer	1.2e-05	0.000153	CcSEcCtD
Estradiol—Dysgeusia—Epirubicin—uterine cancer	1.2e-05	0.000153	CcSEcCtD
Estradiol—Nervousness—Epirubicin—uterine cancer	1.19e-05	0.000151	CcSEcCtD
Estradiol—Back pain—Epirubicin—uterine cancer	1.18e-05	0.000151	CcSEcCtD
Estradiol—Angiopathy—Doxorubicin—uterine cancer	1.18e-05	0.00015	CcSEcCtD
Estradiol—Dizziness—Etoposide—uterine cancer	1.18e-05	0.00015	CcSEcCtD
Estradiol—Muscle spasms—Epirubicin—uterine cancer	1.18e-05	0.00015	CcSEcCtD
Estradiol—Immune system disorder—Doxorubicin—uterine cancer	1.18e-05	0.00015	CcSEcCtD
Estradiol—Mediastinal disorder—Doxorubicin—uterine cancer	1.17e-05	0.000149	CcSEcCtD
Estradiol—Chills—Doxorubicin—uterine cancer	1.17e-05	0.000149	CcSEcCtD
Estradiol—Alopecia—Doxorubicin—uterine cancer	1.15e-05	0.000146	CcSEcCtD
Estradiol—Mental disorder—Doxorubicin—uterine cancer	1.14e-05	0.000145	CcSEcCtD
Estradiol—Ill-defined disorder—Epirubicin—uterine cancer	1.14e-05	0.000145	CcSEcCtD
Estradiol—Vomiting—Etoposide—uterine cancer	1.13e-05	0.000144	CcSEcCtD
Estradiol—Erythema—Doxorubicin—uterine cancer	1.13e-05	0.000144	CcSEcCtD
Estradiol—Malnutrition—Doxorubicin—uterine cancer	1.13e-05	0.000144	CcSEcCtD
Estradiol—Agitation—Epirubicin—uterine cancer	1.13e-05	0.000143	CcSEcCtD
Estradiol—Rash—Etoposide—uterine cancer	1.12e-05	0.000143	CcSEcCtD
Estradiol—Dermatitis—Etoposide—uterine cancer	1.12e-05	0.000143	CcSEcCtD
Estradiol—Headache—Etoposide—uterine cancer	1.12e-05	0.000142	CcSEcCtD
Estradiol—Flatulence—Doxorubicin—uterine cancer	1.12e-05	0.000142	CcSEcCtD
Estradiol—Tension—Doxorubicin—uterine cancer	1.11e-05	0.000141	CcSEcCtD
Estradiol—Dysgeusia—Doxorubicin—uterine cancer	1.11e-05	0.000141	CcSEcCtD
Estradiol—Malaise—Epirubicin—uterine cancer	1.1e-05	0.00014	CcSEcCtD
Estradiol—Nervousness—Doxorubicin—uterine cancer	1.1e-05	0.00014	CcSEcCtD
Estradiol—Vertigo—Epirubicin—uterine cancer	1.1e-05	0.00014	CcSEcCtD
Estradiol—Syncope—Epirubicin—uterine cancer	1.1e-05	0.00014	CcSEcCtD
Estradiol—Back pain—Doxorubicin—uterine cancer	1.1e-05	0.000139	CcSEcCtD
Estradiol—Muscle spasms—Doxorubicin—uterine cancer	1.09e-05	0.000139	CcSEcCtD
Estradiol—Palpitations—Epirubicin—uterine cancer	1.08e-05	0.000138	CcSEcCtD
Estradiol—Loss of consciousness—Epirubicin—uterine cancer	1.08e-05	0.000137	CcSEcCtD
Estradiol—Cough—Epirubicin—uterine cancer	1.07e-05	0.000136	CcSEcCtD
Estradiol—Nausea—Etoposide—uterine cancer	1.06e-05	0.000135	CcSEcCtD
Estradiol—Hypertension—Epirubicin—uterine cancer	1.06e-05	0.000134	CcSEcCtD
Estradiol—Ill-defined disorder—Doxorubicin—uterine cancer	1.05e-05	0.000134	CcSEcCtD
Estradiol—Arthralgia—Epirubicin—uterine cancer	1.04e-05	0.000133	CcSEcCtD
Estradiol—Myalgia—Epirubicin—uterine cancer	1.04e-05	0.000133	CcSEcCtD
Estradiol—Chest pain—Epirubicin—uterine cancer	1.04e-05	0.000133	CcSEcCtD
Estradiol—Agitation—Doxorubicin—uterine cancer	1.04e-05	0.000132	CcSEcCtD
Estradiol—Anxiety—Epirubicin—uterine cancer	1.04e-05	0.000132	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	1.04e-05	0.000132	CcSEcCtD
Estradiol—Discomfort—Epirubicin—uterine cancer	1.03e-05	0.000131	CcSEcCtD
Estradiol—Malaise—Doxorubicin—uterine cancer	1.02e-05	0.00013	CcSEcCtD
Estradiol—Dry mouth—Epirubicin—uterine cancer	1.02e-05	0.00013	CcSEcCtD
Estradiol—Vertigo—Doxorubicin—uterine cancer	1.02e-05	0.00013	CcSEcCtD
Estradiol—Syncope—Doxorubicin—uterine cancer	1.02e-05	0.000129	CcSEcCtD
Estradiol—Confusional state—Epirubicin—uterine cancer	1.01e-05	0.000128	CcSEcCtD
Estradiol—Palpitations—Doxorubicin—uterine cancer	1e-05	0.000127	CcSEcCtD
Estradiol—Oedema—Epirubicin—uterine cancer	1e-05	0.000127	CcSEcCtD
Estradiol—Anaphylactic shock—Epirubicin—uterine cancer	1e-05	0.000127	CcSEcCtD
Estradiol—Loss of consciousness—Doxorubicin—uterine cancer	9.96e-06	0.000127	CcSEcCtD
Estradiol—Infection—Epirubicin—uterine cancer	9.93e-06	0.000126	CcSEcCtD
Estradiol—Cough—Doxorubicin—uterine cancer	9.89e-06	0.000126	CcSEcCtD
Estradiol—Shock—Epirubicin—uterine cancer	9.83e-06	0.000125	CcSEcCtD
Estradiol—Nervous system disorder—Epirubicin—uterine cancer	9.8e-06	0.000125	CcSEcCtD
Estradiol—Hypertension—Doxorubicin—uterine cancer	9.78e-06	0.000124	CcSEcCtD
Estradiol—Tachycardia—Epirubicin—uterine cancer	9.76e-06	0.000124	CcSEcCtD
Estradiol—Skin disorder—Epirubicin—uterine cancer	9.71e-06	0.000123	CcSEcCtD
Estradiol—Hyperhidrosis—Epirubicin—uterine cancer	9.66e-06	0.000123	CcSEcCtD
Estradiol—Chest pain—Doxorubicin—uterine cancer	9.65e-06	0.000123	CcSEcCtD
Estradiol—Myalgia—Doxorubicin—uterine cancer	9.65e-06	0.000123	CcSEcCtD
Estradiol—Arthralgia—Doxorubicin—uterine cancer	9.65e-06	0.000123	CcSEcCtD
Estradiol—Anxiety—Doxorubicin—uterine cancer	9.61e-06	0.000122	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	9.58e-06	0.000122	CcSEcCtD
Estradiol—Discomfort—Doxorubicin—uterine cancer	9.53e-06	0.000121	CcSEcCtD
Estradiol—Dry mouth—Doxorubicin—uterine cancer	9.44e-06	0.00012	CcSEcCtD
Estradiol—Confusional state—Doxorubicin—uterine cancer	9.33e-06	0.000119	CcSEcCtD
Estradiol—Oedema—Doxorubicin—uterine cancer	9.25e-06	0.000118	CcSEcCtD
Estradiol—Anaphylactic shock—Doxorubicin—uterine cancer	9.25e-06	0.000118	CcSEcCtD
Estradiol—Infection—Doxorubicin—uterine cancer	9.19e-06	0.000117	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Epirubicin—uterine cancer	9.11e-06	0.000116	CcSEcCtD
Estradiol—Shock—Doxorubicin—uterine cancer	9.1e-06	0.000116	CcSEcCtD
Estradiol—Nervous system disorder—Doxorubicin—uterine cancer	9.07e-06	0.000115	CcSEcCtD
Estradiol—Insomnia—Epirubicin—uterine cancer	9.04e-06	0.000115	CcSEcCtD
Estradiol—Tachycardia—Doxorubicin—uterine cancer	9.03e-06	0.000115	CcSEcCtD
Estradiol—Skin disorder—Doxorubicin—uterine cancer	8.98e-06	0.000114	CcSEcCtD
Estradiol—Paraesthesia—Epirubicin—uterine cancer	8.98e-06	0.000114	CcSEcCtD
Estradiol—Hyperhidrosis—Doxorubicin—uterine cancer	8.94e-06	0.000114	CcSEcCtD
Estradiol—Dyspnoea—Epirubicin—uterine cancer	8.91e-06	0.000113	CcSEcCtD
Estradiol—Somnolence—Epirubicin—uterine cancer	8.89e-06	0.000113	CcSEcCtD
Estradiol—Dyspepsia—Epirubicin—uterine cancer	8.8e-06	0.000112	CcSEcCtD
Estradiol—Decreased appetite—Epirubicin—uterine cancer	8.69e-06	0.000111	CcSEcCtD
Estradiol—Gastrointestinal disorder—Epirubicin—uterine cancer	8.63e-06	0.00011	CcSEcCtD
Estradiol—Fatigue—Epirubicin—uterine cancer	8.62e-06	0.00011	CcSEcCtD
Estradiol—Pain—Epirubicin—uterine cancer	8.55e-06	0.000109	CcSEcCtD
Estradiol—Constipation—Epirubicin—uterine cancer	8.55e-06	0.000109	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Doxorubicin—uterine cancer	8.43e-06	0.000107	CcSEcCtD
Estradiol—Insomnia—Doxorubicin—uterine cancer	8.36e-06	0.000106	CcSEcCtD
Estradiol—Paraesthesia—Doxorubicin—uterine cancer	8.3e-06	0.000106	CcSEcCtD
Estradiol—Dyspnoea—Doxorubicin—uterine cancer	8.25e-06	0.000105	CcSEcCtD
Estradiol—Feeling abnormal—Epirubicin—uterine cancer	8.24e-06	0.000105	CcSEcCtD
Estradiol—Somnolence—Doxorubicin—uterine cancer	8.22e-06	0.000105	CcSEcCtD
Estradiol—Gastrointestinal pain—Epirubicin—uterine cancer	8.17e-06	0.000104	CcSEcCtD
Estradiol—Dyspepsia—Doxorubicin—uterine cancer	8.14e-06	0.000104	CcSEcCtD
Estradiol—Decreased appetite—Doxorubicin—uterine cancer	8.04e-06	0.000102	CcSEcCtD
Estradiol—Gastrointestinal disorder—Doxorubicin—uterine cancer	7.98e-06	0.000102	CcSEcCtD
Estradiol—Fatigue—Doxorubicin—uterine cancer	7.97e-06	0.000101	CcSEcCtD
Estradiol—Urticaria—Epirubicin—uterine cancer	7.94e-06	0.000101	CcSEcCtD
Estradiol—Pain—Doxorubicin—uterine cancer	7.91e-06	0.000101	CcSEcCtD
Estradiol—Constipation—Doxorubicin—uterine cancer	7.91e-06	0.000101	CcSEcCtD
Estradiol—Abdominal pain—Epirubicin—uterine cancer	7.9e-06	0.000101	CcSEcCtD
Estradiol—Body temperature increased—Epirubicin—uterine cancer	7.9e-06	0.000101	CcSEcCtD
Estradiol—Feeling abnormal—Doxorubicin—uterine cancer	7.62e-06	9.69e-05	CcSEcCtD
Estradiol—Gastrointestinal pain—Doxorubicin—uterine cancer	7.56e-06	9.62e-05	CcSEcCtD
Estradiol—Hypersensitivity—Epirubicin—uterine cancer	7.36e-06	9.37e-05	CcSEcCtD
Estradiol—Urticaria—Doxorubicin—uterine cancer	7.35e-06	9.35e-05	CcSEcCtD
Estradiol—Abdominal pain—Doxorubicin—uterine cancer	7.31e-06	9.3e-05	CcSEcCtD
Estradiol—Body temperature increased—Doxorubicin—uterine cancer	7.31e-06	9.3e-05	CcSEcCtD
Estradiol—Asthenia—Epirubicin—uterine cancer	7.17e-06	9.12e-05	CcSEcCtD
Estradiol—Pruritus—Epirubicin—uterine cancer	7.07e-06	9e-05	CcSEcCtD
Estradiol—Diarrhoea—Epirubicin—uterine cancer	6.84e-06	8.7e-05	CcSEcCtD
Estradiol—Hypersensitivity—Doxorubicin—uterine cancer	6.81e-06	8.67e-05	CcSEcCtD
Estradiol—Asthenia—Doxorubicin—uterine cancer	6.64e-06	8.44e-05	CcSEcCtD
Estradiol—Dizziness—Epirubicin—uterine cancer	6.61e-06	8.41e-05	CcSEcCtD
Estradiol—Pruritus—Doxorubicin—uterine cancer	6.54e-06	8.32e-05	CcSEcCtD
Estradiol—Vomiting—Epirubicin—uterine cancer	6.36e-06	8.08e-05	CcSEcCtD
Estradiol—Diarrhoea—Doxorubicin—uterine cancer	6.33e-06	8.05e-05	CcSEcCtD
Estradiol—Rash—Epirubicin—uterine cancer	6.3e-06	8.02e-05	CcSEcCtD
Estradiol—Dermatitis—Epirubicin—uterine cancer	6.3e-06	8.01e-05	CcSEcCtD
Estradiol—Headache—Epirubicin—uterine cancer	6.26e-06	7.97e-05	CcSEcCtD
Estradiol—Dizziness—Doxorubicin—uterine cancer	6.12e-06	7.78e-05	CcSEcCtD
Estradiol—Nausea—Epirubicin—uterine cancer	5.94e-06	7.55e-05	CcSEcCtD
Estradiol—Vomiting—Doxorubicin—uterine cancer	5.88e-06	7.48e-05	CcSEcCtD
Estradiol—Rash—Doxorubicin—uterine cancer	5.83e-06	7.42e-05	CcSEcCtD
Estradiol—Dermatitis—Doxorubicin—uterine cancer	5.83e-06	7.41e-05	CcSEcCtD
Estradiol—Headache—Doxorubicin—uterine cancer	5.79e-06	7.37e-05	CcSEcCtD
Estradiol—Nausea—Doxorubicin—uterine cancer	5.49e-06	6.99e-05	CcSEcCtD
Estradiol—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.17e-06	0.000119	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—AKR1C1—uterine cancer	3.13e-06	0.000118	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—DCN—uterine cancer	3.13e-06	0.000118	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.13e-06	0.000117	CbGpPWpGaD
Estradiol—ALB—Metabolism—AKR1C1—uterine cancer	3.12e-06	0.000117	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—YWHAE—uterine cancer	3.09e-06	0.000116	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.07e-06	0.000115	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—RRM2—uterine cancer	3.05e-06	0.000114	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—STK11—uterine cancer	3.03e-06	0.000114	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CYP19A1—uterine cancer	3.03e-06	0.000114	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—HRAS—uterine cancer	3.03e-06	0.000114	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—STK11—uterine cancer	3e-06	0.000113	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CYP19A1—uterine cancer	3e-06	0.000113	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CYP19A1—uterine cancer	3e-06	0.000113	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—STK11—uterine cancer	3e-06	0.000113	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—POLD1—uterine cancer	2.99e-06	0.000112	CbGpPWpGaD
Estradiol—ESRRA—Gene Expression—AKT1—uterine cancer	2.99e-06	0.000112	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.98e-06	0.000112	CbGpPWpGaD
Estradiol—AOX1—Disease—NRAS—uterine cancer	2.98e-06	0.000112	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—AKR1B1—uterine cancer	2.97e-06	0.000112	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—STAR—uterine cancer	2.97e-06	0.000112	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—FBXW7—uterine cancer	2.96e-06	0.000111	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—DCN—uterine cancer	2.96e-06	0.000111	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CYP11A1—uterine cancer	2.95e-06	0.000111	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.94e-06	0.00011	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.93e-06	0.00011	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—POLD1—uterine cancer	2.92e-06	0.00011	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—MTHFR—uterine cancer	2.87e-06	0.000108	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—PIK3CA—uterine cancer	2.84e-06	0.000107	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.83e-06	0.000106	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—AKR1C1—uterine cancer	2.8e-06	0.000105	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PTEN—uterine cancer	2.79e-06	0.000105	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—STK11—uterine cancer	2.79e-06	0.000105	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CYP19A1—uterine cancer	2.79e-06	0.000105	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—RRM2—uterine cancer	2.79e-06	0.000105	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CYP11A1—uterine cancer	2.79e-06	0.000105	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—AKR1C3—uterine cancer	2.79e-06	0.000105	CbGpPWpGaD
Estradiol—ALB—Metabolism—RRM2—uterine cancer	2.78e-06	0.000104	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—AKR1C1—uterine cancer	2.73e-06	0.000103	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—POLD1—uterine cancer	2.73e-06	0.000102	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—DCN—uterine cancer	2.71e-06	0.000102	CbGpPWpGaD
Estradiol—NR1I2—Gene Expression—AKT1—uterine cancer	2.7e-06	0.000102	CbGpPWpGaD
Estradiol—ALB—Metabolism—DCN—uterine cancer	2.7e-06	0.000101	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—MTHFR—uterine cancer	2.68e-06	0.000101	CbGpPWpGaD
Estradiol—AOX1—Metabolism—EP300—uterine cancer	2.67e-06	0.0001	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	2.64e-06	9.91e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—AKR1C3—uterine cancer	2.63e-06	9.89e-05	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.6e-06	9.76e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—STK11—uterine cancer	2.59e-06	9.73e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—KRAS—uterine cancer	2.56e-06	9.63e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP11A1—uterine cancer	2.56e-06	9.6e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.55e-06	9.59e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CYP11A1—uterine cancer	2.54e-06	9.55e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.53e-06	9.52e-05	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.51e-06	9.44e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—MTHFR—uterine cancer	2.5e-06	9.4e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—RRM2—uterine cancer	2.49e-06	9.37e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—MTHFR—uterine cancer	2.46e-06	9.24e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—RRM2—uterine cancer	2.43e-06	9.15e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SOCS3—uterine cancer	2.42e-06	9.11e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—DCN—uterine cancer	2.42e-06	9.1e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—AKR1C3—uterine cancer	2.41e-06	9.07e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—AKR1C3—uterine cancer	2.4e-06	9.02e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—DCN—uterine cancer	2.36e-06	8.88e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—PIK3CA—uterine cancer	2.35e-06	8.85e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—POLD1—uterine cancer	2.33e-06	8.76e-05	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—AKT1—uterine cancer	2.32e-06	8.73e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CDKN2B—uterine cancer	2.32e-06	8.72e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.29e-06	8.61e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—STAR—uterine cancer	2.29e-06	8.61e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP11A1—uterine cancer	2.28e-06	8.57e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—MTHFR—uterine cancer	2.28e-06	8.55e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—RRM2—uterine cancer	2.27e-06	8.54e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—MTHFR—uterine cancer	2.26e-06	8.48e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IGF1R—uterine cancer	2.25e-06	8.47e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—MTHFR—uterine cancer	2.25e-06	8.46e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP11A1—uterine cancer	2.23e-06	8.36e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—DCN—uterine cancer	2.21e-06	8.29e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.2e-06	8.28e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—AKR1C1—uterine cancer	2.18e-06	8.19e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—HRAS—uterine cancer	2.18e-06	8.19e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—STK11—uterine cancer	2.17e-06	8.16e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CYP19A1—uterine cancer	2.17e-06	8.16e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.17e-06	8.14e-05	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2.15e-06	8.1e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—AKR1C3—uterine cancer	2.15e-06	8.09e-05	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.12e-06	7.97e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SMAD3—uterine cancer	2.12e-06	7.96e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—AKR1C3—uterine cancer	2.1e-06	7.9e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—MTHFR—uterine cancer	2.1e-06	7.89e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.08e-06	7.81e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—STK11—uterine cancer	2.05e-06	7.7e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CYP19A1—uterine cancer	2.05e-06	7.7e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTEN—uterine cancer	2.04e-06	7.65e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—FGFR2—uterine cancer	2.02e-06	7.59e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTEN—uterine cancer	2e-06	7.51e-05	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PIK3CA—uterine cancer	1.97e-06	7.41e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.96e-06	7.38e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—RRM2—uterine cancer	1.94e-06	7.3e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—EP300—uterine cancer	1.94e-06	7.29e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.92e-06	7.23e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—AKT1—uterine cancer	1.92e-06	7.23e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—EP300—uterine cancer	1.91e-06	7.16e-05	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—AKT1—uterine cancer	1.9e-06	7.15e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—DCN—uterine cancer	1.89e-06	7.09e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.88e-06	7.06e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—STK11—uterine cancer	1.88e-06	7.06e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—STK11—uterine cancer	1.87e-06	7.02e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CYP19A1—uterine cancer	1.87e-06	7.02e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—EP300—uterine cancer	1.84e-06	6.91e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.84e-06	6.9e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—POLD1—uterine cancer	1.8e-06	6.76e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.78e-06	6.68e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.76e-06	6.63e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.75e-06	6.59e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—VEGFA—uterine cancer	1.74e-06	6.54e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—NRAS—uterine cancer	1.72e-06	6.46e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.68e-06	6.32e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.68e-06	6.32e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.68e-06	6.31e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—STK11—uterine cancer	1.68e-06	6.3e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.68e-06	6.3e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.67e-06	6.29e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—STK11—uterine cancer	1.64e-06	6.15e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP19A1—uterine cancer	1.64e-06	6.15e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—MTHFR—uterine cancer	1.63e-06	6.13e-05	CbGpPWpGaD
Estradiol—AOX1—Metabolism—AKT1—uterine cancer	1.61e-06	6.05e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTEN—uterine cancer	1.6e-06	6.01e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.57e-06	5.92e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—MTHFR—uterine cancer	1.54e-06	5.79e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—STK11—uterine cancer	1.53e-06	5.75e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.53e-06	5.75e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—EP300—uterine cancer	1.53e-06	5.73e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCL2—uterine cancer	1.52e-06	5.72e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.5e-06	5.64e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—RRM2—uterine cancer	1.5e-06	5.63e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTEN—uterine cancer	1.49e-06	5.61e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—KRAS—uterine cancer	1.48e-06	5.56e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—DCN—uterine cancer	1.46e-06	5.47e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.44e-06	5.4e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PIK3CA—uterine cancer	1.44e-06	5.4e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—EP300—uterine cancer	1.42e-06	5.35e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—MTHFR—uterine cancer	1.41e-06	5.31e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PIK3CA—uterine cancer	1.41e-06	5.3e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—MTHFR—uterine cancer	1.4e-06	5.28e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTEN—uterine cancer	1.39e-06	5.23e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.37e-06	5.15e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.37e-06	5.15e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTEN—uterine cancer	1.37e-06	5.14e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—PIK3CA—uterine cancer	1.36e-06	5.11e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.36e-06	5.1e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—EP300—uterine cancer	1.33e-06	4.99e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—uterine cancer	1.32e-06	4.94e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.31e-06	4.91e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—STK11—uterine cancer	1.31e-06	4.91e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—EP300—uterine cancer	1.3e-06	4.9e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.3e-06	4.87e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—ERBB2—uterine cancer	1.27e-06	4.77e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTEN—uterine cancer	1.27e-06	4.76e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—MTHFR—uterine cancer	1.26e-06	4.74e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—HRAS—uterine cancer	1.26e-06	4.73e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTEN—uterine cancer	1.26e-06	4.72e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTEN—uterine cancer	1.25e-06	4.71e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—AKT1—uterine cancer	1.24e-06	4.68e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.24e-06	4.68e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.24e-06	4.65e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—MTHFR—uterine cancer	1.23e-06	4.62e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.23e-06	4.61e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—EP300—uterine cancer	1.21e-06	4.54e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCL8—uterine cancer	1.2e-06	4.52e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—EP300—uterine cancer	1.2e-06	4.5e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—EP300—uterine cancer	1.2e-06	4.49e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CDKN1B—uterine cancer	1.18e-06	4.42e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—AKT1—uterine cancer	1.17e-06	4.41e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.17e-06	4.4e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTEN—uterine cancer	1.17e-06	4.39e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—AKT1—uterine cancer	1.15e-06	4.33e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—MTHFR—uterine cancer	1.15e-06	4.32e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PIK3CA—uterine cancer	1.13e-06	4.24e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—EP300—uterine cancer	1.11e-06	4.19e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.11e-06	4.18e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—AKT1—uterine cancer	1.11e-06	4.17e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CTNNB1—uterine cancer	1.11e-06	4.17e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTEN—uterine cancer	1.08e-06	4.07e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PIK3CA—uterine cancer	1.05e-06	3.96e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EP300—uterine cancer	1.03e-06	3.88e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.01e-06	3.81e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—STK11—uterine cancer	1.01e-06	3.79e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.01e-06	3.79e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—MTHFR—uterine cancer	9.82e-07	3.69e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CA—uterine cancer	9.82e-07	3.69e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—VEGFA—uterine cancer	9.77e-07	3.67e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NRAS—uterine cancer	9.65e-07	3.63e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CA—uterine cancer	9.65e-07	3.63e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—AKT1—uterine cancer	9.59e-07	3.6e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—AKT1—uterine cancer	9.22e-07	3.46e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTEN—uterine cancer	9.07e-07	3.41e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CA—uterine cancer	8.93e-07	3.36e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CA—uterine cancer	8.85e-07	3.33e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CA—uterine cancer	8.84e-07	3.32e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.66e-07	3.25e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—EP300—uterine cancer	8.65e-07	3.25e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—AKT1—uterine cancer	8.6e-07	3.23e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTEN—uterine cancer	8.57e-07	3.22e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KRAS—uterine cancer	8.31e-07	3.12e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CA—uterine cancer	8.24e-07	3.1e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—EP300—uterine cancer	8.17e-07	3.07e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—AKT1—uterine cancer	8.02e-07	3.01e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—AKT1—uterine cancer	7.88e-07	2.96e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTEN—uterine cancer	7.86e-07	2.95e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTEN—uterine cancer	7.81e-07	2.94e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CA—uterine cancer	7.63e-07	2.87e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—MTHFR—uterine cancer	7.58e-07	2.85e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—EP300—uterine cancer	7.49e-07	2.82e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—EP300—uterine cancer	7.45e-07	2.8e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—uterine cancer	7.38e-07	2.77e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—AKT1—uterine cancer	7.3e-07	2.74e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—AKT1—uterine cancer	7.23e-07	2.72e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—AKT1—uterine cancer	7.22e-07	2.71e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HRAS—uterine cancer	7.06e-07	2.65e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTEN—uterine cancer	7.01e-07	2.64e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTEN—uterine cancer	6.85e-07	2.57e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—AKT1—uterine cancer	6.73e-07	2.53e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—EP300—uterine cancer	6.69e-07	2.51e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—EP300—uterine cancer	6.53e-07	2.45e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CA—uterine cancer	6.4e-07	2.41e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTEN—uterine cancer	6.4e-07	2.4e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—AKT1—uterine cancer	6.24e-07	2.34e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—EP300—uterine cancer	6.1e-07	2.29e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CA—uterine cancer	6.05e-07	2.27e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CA—uterine cancer	5.54e-07	2.08e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CA—uterine cancer	5.51e-07	2.07e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTEN—uterine cancer	5.47e-07	2.05e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—AKT1—uterine cancer	5.23e-07	1.96e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—EP300—uterine cancer	5.21e-07	1.96e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CA—uterine cancer	4.95e-07	1.86e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—AKT1—uterine cancer	4.94e-07	1.86e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CA—uterine cancer	4.83e-07	1.81e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—AKT1—uterine cancer	4.53e-07	1.7e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CA—uterine cancer	4.51e-07	1.7e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—AKT1—uterine cancer	4.5e-07	1.69e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTEN—uterine cancer	4.22e-07	1.58e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—AKT1—uterine cancer	4.04e-07	1.52e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—EP300—uterine cancer	4.02e-07	1.51e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—AKT1—uterine cancer	3.95e-07	1.48e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CA—uterine cancer	3.86e-07	1.45e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—AKT1—uterine cancer	3.69e-07	1.39e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—AKT1—uterine cancer	3.15e-07	1.18e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.98e-07	1.12e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—AKT1—uterine cancer	2.43e-07	9.13e-06	CbGpPWpGaD
